Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valaciclovir for CMV reactivation in ANCA-associated vasculitis
NCT01633476Phase 2Unknown
- Start
- Jul 2013
- Primary completion
- Feb 2016
- Countries
- 1
01
Overview
A Phase 2 trial of valaciclovir in cytomegalovirus infection (CMV). Status: unknown.
02
Drugs
valaciclovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT01633476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01633476.